Clinical Trials Directory

Trials / Unknown

UnknownNCT04907513

Amotivational Syndrome and Fatigue in Neurosurgery

Amotivational Syndrome and Fatigue in Neurosurgery: The Impact of Neuroinflammation

Status
Unknown
Phase
Study type
Observational
Enrollment
25 (estimated)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
18 Years – 95 Years
Healthy volunteers
Not accepted

Summary

Depression is a major public concern associated with profound distress, intense suffering, and impairment in social, professional and familial functioning. Among the numerous symptoms defining depression, fatigue and motivation are not only frequent but also highly associated with poor quality of life and resistance to conventional antidepressant. Recent data, mainly obtained in animals, suggest that these symptoms may be linked to inflammatory processes within the central nervous system. Yet access to the brain is too invasive for exploring this link in patients with psychiatric conditions. However, certain conditions in neurosurgery, such as aneurysm rupture, require external evacuation, over several days or weeks, of the fluid bathing the brain through a catheter directly inserted into it. Critically, these patients also exhibit extreme exhaustion and fluctuating motivation, allowing to investigate the involvement of neuroinflammation in lack of motivation and fatigue by carrying out repeated motivation assessments with short behavioral tests (around ten minutes), while performing an analysis of inflammation markers in the fluid evacuated from the brain. The identification of inflammatory mechanisms underlying lack of motivation and fatigue could lead to the development of treatments for both resistant depression and motivation deficits that largely hamper rehabilitation in neurosurgery.

Conditions

Interventions

TypeNameDescription
OTHERAssessment of the Motivational StateA motivational interviewing algorithm developed in Rothschild Hospital for this study will be used. The results range between 0% (worst motivational state) to 100% (best motivational state).

Timeline

Start date
2021-12-04
Primary completion
2023-12-04
Completion
2024-12-01
First posted
2021-05-28
Last updated
2023-02-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04907513. Inclusion in this directory is not an endorsement.